MSB 2.89% $1.25 mesoblast limited

Yep, totally take your point - although specifically for COVID19...

  1. 37 Posts.
    lightbulb Created with Sketch. 1
    Yep, totally take your point - although specifically for COVID19 I'm optimistic of a vaccine which will largely reduce the need for remestemcel-l to treat COVID19 patients with ARDS.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.